Zoetis | ZTS - Equity Capital And Reserves


Zoetis reported $3.23B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
AbbVie USD -6.66B 3.39B Mar/2026
Align Technology USD 4.15B 100.27M Mar/2026
Bayer EUR 28.85B 2.9B Mar/2026
Bristol-Myers Squibb USD 20.07B 1.6B Mar/2026
Charles River Laboratories USD 2.9B 265.94M Mar/2026
Coherus Biosciences USD 61.01M 26.76M Dec/2025
Dentsply International USD 1.32B 21M Mar/2026
Eli Lilly USD 31.2B 4.66B Mar/2026
Henry Schein USD 3.27B 21M Mar/2026
Idexx Laboratories USD 1.56B 49.28M Mar/2026
Illumina USD 2.68B 47M Mar/2026
IQVIA Holdings USD 6.22B 282M Mar/2026
J&J USD 81.19B 358M Mar/2026
Laboratory Of America USD 8.73B 108.8M Mar/2026
Merck USD 45.88B 6.73B Mar/2026
Neogen USD 2.1B 2.09M Dec/2025
Pacira USD 653.89M 39.22M Mar/2026
Perrigo USD 2.5B 436.7M Mar/2026
Pfizer USD 90.1B 3.63B Mar/2026
Phibro Animal Health USD 361.83M 29.47M Mar/2026
Quest Diagnostics USD 7.37B 196M Mar/2026
Sanofi EUR 72.81B 1.1B Mar/2026
Sanofi EUR 71.71B 14.25B Dec/2025
Zoetis USD 3.23B 98M Mar/2026